⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development of Targeted Radiotherapeutics Pipeline and Expand Manufacturing Infrastructure
prnewswire.com
BMY
LLY
NVS
Questex’s Fierce Pharma announces launch of Fierce Pharma Week Europe in Basel, Switzerland in June 2027
globenewswire.com
NVS
Global Radiopharmaceutical CDMO Market to Accelerate Substantially at a CAGR of ~10% by 2034 | DelveInsight
globenewswire.com
TMO
MRK
DHR
LNT
THC
GEHC
NVS
LLY
AZN
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
prnewswire.com
CYTK
NVO
BCDA
AZN
BMY
LLY
MESO
ASMB
LXRX
VTRS
AMGN
IRWD
NVS
MRK
New Ebook Reveals What New CCOs Need to Get Right in the First Six Months
globenewswire.com
ABT
AMST
GIS
KMB
LMT
NVS
SCL
Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight
prnewswire.com
DBVT
NVS
AQST
GSK
REGN
Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight
globenewswire.com
BMY
PFE
AMGN
NVS
MRK
LLY
GILD
AZN
TAK
JNJ
ABBV
CRSP
MOD
ARVN
ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight
prnewswire.com
PFE
MRK
LLY
AMGN
BMY
NVS
GILD
AZN
REGN
SNY
TEVA
IMUX
Novartis verzeichnete im zweiten Quartal Umsatzsteigerungen und baute die Pipeline weiter aus; Prognose für das Geschäftsjahr bekräftigt
globenewswire.com
NVS
Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed
globenewswire.com
NVS